Chief Product Officer · RESMED INC (RMD)

Justin Leong

A named executive officer of RESMED in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$3,911,441

FY2024: $3,597,240

2nd of 5 named executive officers at Resmed by FY2025 total.

5 named officers on file for RESMED, FY2025

See an example →

What this number hides

The filing gives the total. RESMED’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed October 1, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-07.

Free

Get Justin Leong’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Justin Leong and every company like it: Velarion Intel, free for 3 days, no card →

Justin Leong compensation by year

RESMED Summary Compensation Table · all 3 fiscal years held
In US dollars, as RESMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025FY2026
Salary$586,305$677,032$752,928
Bonus$0$0$0
Stock awards$2,399,823$2,600,037$3,099,837
Option awards$0$0$0
Non-equity incentive$497,856$552,478$609,510
Pension and deferred compensation$0$0$0
All other$113,256$81,894$94,846
Total$3,597,240$3,911,441$4,557,121

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RESMED INC DEF 14A filed October 1, 2026, accession 0000943819-26-000080, and prior-year filings. Open the filing on EDGAR.

How this page was built: the RESMED INC filed document, accession 0000943819-26-000080. Every figure is read from that document and cited to the page and table it appears in. Filed October 1, 2026.

$3.6M
$3.9M
$4.6M
FY24
FY25
FY26
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2026 year-end
TypeUnvested unitsValue at year-endExercise price
PSU6,461$1,259,120—
RSU6,395$1,246,258—
PSU6,146$1,197,732—
PSU3,624$706,245—
PSU1,471$286,668—
PSU1,245$242,626—
PSU1,219$237,559—
PSU1,050$204,624—
RSU878$171,105—

Per the Outstanding Equity Awards at Fiscal Year-End table in RESMED INC's FY2026 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2025 proxy (filed October 1, 2026)
current to 2026-11-07 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-08-14Grant or award—6,461$0.0035,489

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments RESMED discloses, by trigger · FY2026
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Change in control, no termination$0$1,970,089$0$1,970,089
Change in control and involuntary termination$2,764,330$2,505,377$6,877$5,276,584
Disability$0$5,938,188$345,700$6,283,888
Death$0$5,938,188$345,700$6,283,888
Involuntary termination without cause$0$1,260,833$0$1,260,833

Per the Potential Payments Upon Termination or Change in Control table in RESMED INC's FY2026 proxy. Estimates as the company printed them; a dash means it printed no figure.

RESMED’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Michael FarrellChairman of the Board and Chief Executive Officer$14,674,543
Justin Leong · this pageChief Product Officer$3,911,441
Bobby GhoshalChief Commercial Officer, Residential Care Software$3,652,455
Brett SandercockChief Financial Officer$3,572,010
Michael RiderGlobal General Counsel and Secretary$2,289,122

The full RESMED compensation record

free company brief

This page is one person within RESMED's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the RESMED proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order RESMED's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are RESMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order RMD

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Justin Leong's compensation dossier